Scarica l'app Stockscreener
63.25
3.27%
-2.14
Dopo l'orario di chiusura:
62.70
-0.55
-0.87%
Precedente Chiudi:
$65.39
Aprire:
$65.85
Volume 24 ore:
518.33K
Relative Volume:
1.00
Capitalizzazione di mercato:
$2.68B
Reddito:
$17.39M
Utile/perdita netta:
$-135.89M
Rapporto P/E:
-13.63
EPS:
-4.64
Flusso di cassa netto:
$-123.00M
1 W Prestazione:
+2.03%
1M Prestazione:
-16.26%
6M Prestazione:
+23.15%
1 anno Prestazione:
+20.87%
Intervallo 1D:
$62.15
$66.40
Intervallo di 1 settimana:
$62.15
$67.70
Portata 52W:
$38.51
$85.25
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Nome
Tarsus Pharmaceuticals Inc
Settore
Industria
Telefono
(949) 409-9820
Indirizzo
15440 LAGUNA CANYON ROAD, IRVINE
Compare TARS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
63.25 | 2.78B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-20 | Iniziato | Mizuho | Outperform |
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-27 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-20 | Iniziato | Goldman | Neutral |
| 2023-07-18 | Iniziato | William Blair | Outperform |
| 2023-05-18 | Iniziato | Guggenheim | Buy |
| 2022-08-01 | Iniziato | Barclays | Overweight |
| 2021-12-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-23 | Iniziato | Oppenheimer | Outperform |
| 2020-11-10 | Iniziato | BofA Securities | Buy |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-11-10 | Iniziato | Raymond James | Strong Buy |
Mostra tutto
Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie
Why is Tarsus Pharmaceuticals Inc stock going down2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Panic Selling: Is Tarsus Pharmaceuticals Inc still a buy after recent gainsJuly 2025 Levels & Reliable Intraday Trade Plans - baoquankhu1.vn
Federated Hermes Inc. Has $905,000 Stock Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price - simplywall.st
Liquidity Mapping Around (TARS) Price Events - Stock Traders Daily
Dow Update: Does Tarsus Pharmaceuticals Inc have declining or rising EPS2025 EndofYear Setup & Daily Profit Focused Screening - baoquankhu1.vn
Stocks to watch: Tarsus Pharmaceuticals sees RS rating rise to 81 - MSN
Lisanti Capital Growth LLC Has $2.56 Million Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus prices $125M stock offering - MSN
Does Tarsus Pharmaceuticals Inc have declining or rising EPSBuy Signal & Intraday High Probability Setup Alerts - baoquankhu1.vn
Will Tarsus Pharmaceuticals Inc. benefit from green energy policies2025 Key Highlights & High Win Rate Trade Alerts - mfd.ru
Investors Still Waiting For A Pull Back In Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - 富途牛牛
Tarsus Pharmaceuticals Shares Show Resilience Amid Market Pressure - AD HOC NEWS
Hussman Strategic Advisors Inc. Purchases Shares of 31,500 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Volume Report: How does DMC Global Inc correlate with Nasdaq2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Universal Beteiligungs und Servicegesellschaft mbH Has $5.44 Million Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Down 16.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Tarsus Pharmaceuticals (TARS) - Finviz
SG Americas Securities LLC Sells 27,833 Shares of Tarsus Pharmaceuticals, Inc. $TARS - Defense World
Why (TARS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. $TARS Shares Purchased by Jennison Associates LLC - MarketBeat
Portfolio Update: Does Tarsus Pharmaceuticals Inc have declining or rising EPSQuarterly Earnings Report & Long-Term Growth Plans - baoquankhu1.vn
Relative Strength Alert For Tarsus Pharmaceuticals - Nasdaq
Does Tarsus Pharmaceuticals (NASDAQ:TARS) Have A Healthy Balance Sheet? - simplywall.st
While shareholders of Tarsus Pharmaceuticals (NASDAQ:TARS) are in the black over 3 years, those who bought a week ago aren't so fortunate - Yahoo Finance
Understanding Momentum Shifts in (TARS) - Stock Traders Daily
BMRN or TARS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Aug PostEarnings: Why Tarsus Pharmaceuticals Inc. stock could rally in 20252025 Bull vs Bear & AI Based Trade Execution Alerts - Bộ Nội Vụ
Tarsus Pharmaceuticals, Inc. Publishes Corporate Presentation on Eye Care Innovations - TradingView — Track All Markets
What analyst consensus says on Tarsus Pharmaceuticals Inc. stockStop Loss & Smart Allocation Stock Tips - Улправда
Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersPortfolio Value Report & Real-Time Stock Entry Alerts - Улправда
Growth Recap: Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersMarket Activity Summary & Free Long-Term Investment Growth Plans - Улправда
Will Tarsus Pharmaceuticals Inc. stock outperform tech sector in 2025Portfolio Gains Summary & Free Real-Time Volume Trigger Notifications - Улправда
Tarsus Pharmaceuticals (NASDAQ:TARS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - 富途牛牛
Insider Sell Alert: Dianne Whitfield Sells 15,565 Shares of Tarsus Pharmaceuticals Inc (TARS) - GuruFocus
Avoiding Lag: Real-Time Signals in (TARS) Movement - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Bobak Azamian Sells 6,000 Shares - MarketBeat
Tarsus Pharmaceuticals Insider Sold Shares Worth $495,089, According to a Recent SEC Filing - MarketScreener
Tarsus Pharmaceuticals (TARS) Investor Outlook: Strong Buy Ratings and Promising Revenue Growth in Biotech - DirectorsTalk Interviews
Will Tarsus Pharmaceuticals Inc. stock split attract more investorsDividend Cut Warnings & Low Risk Investment Plans - bollywoodhelpline.com
Tarsus to Participate at the Bank of America 2023 Healthcare Conference - 富途牛牛
240,020 Shares in Tarsus Pharmaceuticals, Inc. $TARS Purchased by Capricorn Fund Managers Ltd - MarketBeat
Tarsus Pharmaceuticals Earnings Notes - Trefis
Market Sentiment Around Loss-Making Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - simplywall.st
Will Tarsus Pharmaceuticals Inc. stock see PE expansionTake Profit Strategies & Free Hedging Tactics for Volatile Markets - Bollywood Helpline
Tarsus Pharmaceuticals (TARS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Technical Reactions to TARS Trends in Macro Strategies - Stock Traders Daily
Why Tarsus Pharmaceuticals Inc. stock could rally in 2025July 2025 Opening Moves & Weekly Breakout Watchlists - Улправда
Can Tarsus Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):